Medacta Group (Switzerland) Analysis
| MOVE Stock | 148.60 0.80 0.54% |
200 Day MA 147.895 | 50 Day MA 159.3 | Beta 1.179 |
At this time, Medacta Group's Debt To Equity is fairly stable compared to the past year. Debt Equity Ratio is likely to climb to 0.88 in 2026, whereas Net Debt is likely to drop slightly above 123.6 M in 2026. Medacta Group's financial risk is the risk to Medacta Group stockholders that is caused by an increase in debt.
Debt Ratio | First Reported 2010-12-31 | Previous Quarter 0.27 | Current Value 0.24 | Quarterly Volatility 0.08038614 |
Medacta Group SA is overvalued with Real Value of 130.77 and Hype Value of 148.63. The main objective of Medacta Group stock analysis is to determine its intrinsic value, which is an estimate of what Medacta Group SA is worth, separate from its market price. There are two main types of Medacta Group's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Medacta Group's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Medacta Group's stock to identify patterns and trends that may indicate its future price movements.
The Medacta Group stock is traded in Switzerland on SIX Swiss Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Switzerland. Medacta Group is usually not traded on Christmas Eve ( 2025 ), Christmas Day, St . Stephen 's Day, New Year 's Eve ( 2025 ), New Year 's Day, Berchtoldstag, Good Friday, Easter Monday, International Workers ' Day, National Day. Medacta Stock trading window is adjusted to Europe/Zurich timezone.
Medacta |
Medacta Stock Analysis Notes
About 70.0% of the company outstanding shares are owned by corporate insiders. The company last dividend was issued on the 9th of May 2025. To find out more about Medacta Group SA contact the company at 41 91 696 60 60 or learn more at https://www.medacta.com.Medacta Group Quarterly Total Revenue |
|
Medacta Group SA Investment Alerts
| Medacta Group SA generated a negative expected return over the last 90 days | |
| About 70.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Berenberg Bank Maintains MEDACTA GROUP SA With Buy Rating, Raises Target Price to 226.75 - |
Medacta Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.95 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medacta Group's market, we take the total number of its shares issued and multiply it by Medacta Group's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Medacta Profitablity
Medacta Group's profitability indicators refer to fundamental financial ratios that showcase Medacta Group's ability to generate income relative to its revenue or operating costs. If, let's say, Medacta Group is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Medacta Group's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Medacta Group's profitability requires more research than a typical breakdown of Medacta Group's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.15 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.18 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.18. | Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.10 | 0.11 | |
| Return On Capital Employed | 0.16 | 0.20 | |
| Return On Assets | 0.11 | 0.10 | |
| Return On Equity | 0.22 | 0.26 |
Management Efficiency
Medacta Group SA has return on total asset (ROA) of 0.0848 % which means that it generated a profit of $0.0848 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.247 %, meaning that it generated $0.247 on every $100 dollars invested by stockholders. Medacta Group's management efficiency ratios could be used to measure how well Medacta Group manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Medacta Group's Return On Tangible Assets are fairly stable compared to the past year. Return On Capital Employed is likely to climb to 0.20 in 2026, whereas Return On Assets are likely to drop 0.10 in 2026. At this time, Medacta Group's Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to climb to about 25.2 M in 2026, whereas Non Current Assets Total are likely to drop slightly above 234 M in 2026.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 17.09 | 17.94 | |
| Tangible Book Value Per Share | 14.67 | 15.41 | |
| Enterprise Value Over EBITDA | 17.75 | 24.70 | |
| Price Book Value Ratio | 6.87 | 12.45 | |
| Enterprise Value Multiple | 17.75 | 24.70 | |
| Price Fair Value | 6.87 | 12.45 | |
| Enterprise Value | 2.2 B | 1.9 B |
Leadership effectiveness at Medacta Group SA is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Technical Drivers
As of the 17th of February 2026, Medacta Group secures the Mean Deviation of 1.19, risk adjusted performance of 0.05, and Downside Deviation of 1.71. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medacta Group SA, as well as the relationship between them. Please verify Medacta Group SA coefficient of variation, variance, and the relationship between the downside deviation and standard deviation to decide if Medacta Group SA is priced some-what accurately, providing market reflects its recent price of 148.6 per share.Medacta Group SA Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Medacta Group middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Medacta Group SA. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Medacta Group Outstanding Bonds
Medacta Group issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Medacta Group SA uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Medacta bonds can be classified according to their maturity, which is the date when Medacta Group SA has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Medacta Group Predictive Daily Indicators
Medacta Group intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Medacta Group stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Medacta Group Forecast Models
Medacta Group's time-series forecasting models are one of many Medacta Group's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Medacta Group's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Medacta Group Total Assets Over Time
Medacta Group Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Medacta Group uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Medacta Group Debt Ratio | 24.0 |
Medacta Group Corporate Bonds Issued
Medacta Short Long Term Debt Total
Short Long Term Debt Total |
|
About Medacta Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Medacta Group prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Medacta shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Medacta Group. By using and applying Medacta Stock analysis, traders can create a robust methodology for identifying Medacta entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | 0.15 | 0.17 | |
| Operating Profit Margin | 0.18 | 0.19 | |
| Net Profit Margin | 0.14 | 0.13 | |
| Gross Profit Margin | 0.78 | 0.79 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Medacta Group to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
Additional Tools for Medacta Stock Analysis
When running Medacta Group's price analysis, check to measure Medacta Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medacta Group is operating at the current time. Most of Medacta Group's value examination focuses on studying past and present price action to predict the probability of Medacta Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medacta Group's price. Additionally, you may evaluate how the addition of Medacta Group to your portfolios can decrease your overall portfolio volatility.